Ercros, S.A. (BME:ECR)

Market Cap	312.25M +18.8%
Revenue (ttm)	628.69M -5.9%
Net Income	-53.59M
EPS	-0.59
Shares Out	91.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	184,396
Average Volume	215,296
Open	3.410
Previous Close	3.415
Day's Range	3.410 - 3.425
52-Week Range	2.230 - 3.475
Beta	0.27
RSI	54.50
Earnings Date	Feb 27, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,329
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.